uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Essential thrombocythaemia treatment options: addressing patient-specific needs
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences. (Hematologi)
2007 (English)In: European Journal of Haematology, ISSN 0902-4441, E-ISSN 1600-0609, Vol. 79, no s68, 27-31 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2007. Vol. 79, no s68, 27-31 p.
Keyword [en]
essential thrombocythaemia, myeloproliferative disorders, treatment, risk assessment, leukaemia, hydroxyurea, anagrelide, interferon, adverse effects
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-11424DOI: 10.1111/j.1600-0609.2007.00941.xISI: 000248977100009PubMedID: 17727563OAI: oai:DiVA.org:uu-11424DiVA: diva2:39193
Conference Information: Outflow form New Horizons in Haematology Meeting Sheffield, ENGLAND, MAR 09-10, 2007 Available from: 2007-09-13 Created: 2007-09-13 Last updated: 2011-04-13Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Department of Medical Sciences
In the same journal
European Journal of Haematology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 169 hits
ReferencesLink to record
Permanent link

Direct link